Search

The Ethiopian private health sector is growing in size and scope. Over one-third of Ethiopian health expenditures go to private providers but the quality and availability of private providers’ priority health services is uneven. The government’s plans…

Despite tremendous economic growth, many Tanzanians remain underserved by public services and lack reliable access to essential medicines.

Abt helped a nonprofit prepare to deliver Enhanced Care Management services under California’s CalAIM Medicaid program.

In Global Health Science and Practice, Abt Global’s Kelly Saldana and coauthors argue for more evidence and coordination to expand the use of Networks of Care in health systems and service strengthening.

Sickle cell disease (SCD) is an inherited blood condition that affects an estimated 100,000 individuals in the United States, many of whom are Black and Hispanic Americans. While newborn screening for SCD occurs in every state, there…

Implemented by the California Department of Social Services (CDSS) and counties across California, the Project Roomkey (PRK) Program was a statewide effort to protect people experiencing homelessness by giving them an alternative to staying on the street…

Through the Trade Adjustment Assistance Community College and Career Training (TAACCCT) program, the U.S. Department of Labor provided four rounds of grants to community colleges and other eligible institutions of higher education to expand and improve…

Primary care practices need to redesign the way they provide care to balance preventing opioid misuse and potential risks while addressing the needs of patients with chronic pain. The Agency for Healthcare Research and Quality (AHRQ) awarded Abt a…

Having graduated from EPA’s peer review process, the Abt-designed SWEET tool has been updated to better identify and resolve methane emissions.

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.